IMAX executive sells 443,159 shares for $17.0M

IMAX reported that Richard Gelfond executed multiple sales of Common Stock reported on Form 144, totaling 443,159 shares.

Rhea-AI Filing Summary

IMAX reported that Richard Gelfond executed multiple sales of Common Stock reported on Form 144, totaling 443,159 shares. The filing lists discrete dispositions on 03/10/2026, 04/02/2026, 04/06/2026, 04/10/2026, 04/13/2026, 04/14/2026, 04/15/2026, and 04/16/2026

The listed proceeds sum to $16,979,793.05 across those transactions; the sales are shown as dispositions of shares acquired under stock options on 06/07/2016 via cashless exercise/same-day sale.

Insights

Insider Transactions Analyst

CEO-affiliated sales: multiple open-market dispositions totaling 443,159 shares, proceeds ~ $17.0M.

The notices list eight transactions by Richard Gelfond between 03/10/2026 and 04/16/2026, showing shares acquired under stock options dated 06/07/2016 and sold via cashless exercise/same-day sale. The filing provides exact per-trade share counts and gross proceeds.

These are reported dispositions rather than corporate actions; cash-flow shows proceeds to the selling holder. Subsequent filings may show remaining holdings or confirm whether sales were pursuant to a trading plan.

Key Figures

Total shares sold (listed): 443,159 shares Aggregate proceeds (listed): $16,979,793.05 Largest single trade: 135,046 shares +3 more

6 metrics

Total shares sold (listed) 443,159 shares sum of eight dispositions between 03/10/2026 and 04/16/2026

Aggregate proceeds (listed) $16,979,793.05 sum of per‑trade gross proceeds shown in excerpt

Largest single trade 135,046 shares trade dated 04/10/2026 with proceeds $5,106,872.53

Notable trade 121,220 shares trade dated 03/10/2026 with proceeds $4,860,837.15

Acquisition method Stock options (06/07/2016) shares acquired as compensation under options dated 06/07/2016

Disposition method Cashless exercise / same-day sale method shown for listed dispositions

Key Terms

cashless exercise, Form 144, stock options

3 terms

cashless exercise financial

"Compensation -- Cashless exercise / same-day sale"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

Form 144 regulatory

"Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock options financial

"Acquired as compensation -- Stock Options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IMAX (IMAX) disclose about Richard Gelfond's stock sales?

The filing shows Richard Gelfond sold a series of common-share blocks on specified dates. The excerpt lists eight dispositions totaling 443,159 shares for aggregate proceeds of $16,979,793.05, with shares acquired under 06/07/2016 stock options and sold via cashless exercise/same-day sale.

How many shares did Richard Gelfond sell and when were the trades reported?

The content lists eight transactions between 03/10/2026 and 04/16/2026 totaling 443,159 shares. Each trade is recorded with its specific date, share count, and gross proceeds in the filing excerpt.

Were the sold shares acquired as compensation or purchased previously?

Yes; the excerpt explicitly states the shares were acquired as compensation from stock options dated 06/07/2016. The listed method for the dispositions is cashless exercise with same-day sale.

How much gross proceeds did the reported sales generate?

The listed per-trade proceeds sum to $16,979,793.05 across the eight transactions. Each transaction line in the excerpt shows the gross dollar amount associated with that specific disposition.

Does the filing state whether these sales were under a pre-arranged trading plan?

The provided excerpt does not state that the transactions were made pursuant to a Rule 10b5-1 or any trading plan. The method shown is cashless exercise/same-day sale; no trading-plan language appears in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 05:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corporation
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga Unknown L5K 1B1
Phone	1-905-403-6457
Name of Person for Whose Account the Securities are To Be Sold	Richard Gelfond
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	34182	1199446.38	53993017	04/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	06/07/2016	Acquired as compensation -- Stock Options	Issuer			34182	06/07/2016	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	03/10/2026	121220	4860837.15
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/10/2026	135046	5106872.53
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/02/2026	12037	481520.93
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/06/2026	12987	522883.89
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/13/2026	97462	3620966.7
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/14/2026	6924	256657.45
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/15/2026	15746	583715.24
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/16/2026	41737	1546339.16

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 12/9/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	04/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Richard Gelfond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)